Research Atlas · source screening

Cyclosporine

An attributable first-pass index of PubMed records whose titles name this governed identity. Records are sorted by publication date, not by evidence strength. Inclusion does not establish efficacy, safety, or a clinical indication.

Scope: Single-source, name-in-title discovery sample. Not a systematic review, worldwide source coverage, clinical appraisal, efficacy or safety conclusion, or complete WPF profile. This source index is separate from the Public Peptide Directory and from human observations.

Title-search results: 14,077
Shown with stable PMIDs: 25
Search recorded: 2026-09-26

Source: NCBI PubMed / MEDLINE · exact query: "Cyclosporine"[Title] · up to 25 recent title matches per identity. Each result links to its PubMed record.

Alpha-synuclein and mitochondrial permeability transition pore interactions in rotenone-induced Parkinson's disease models: neuroprotective promise of cyclosporine A.
Biochem Biophys Rep · 2026 Dec · PMID 42755993 · DOI 10.1016/j.bbrep.2026.102783
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Cyclosporine A improves survival in lower-risk hypoplastic myelodysplastic syndromes: a single-center retrospective study from China.
Hematology · 2026 Dec · PMID 41410496 · DOI 10.1080/16078454.2025.2605379
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Evaluation of the effects of alpha-lipoic acid on cyclosporine-induced memory dysfunction and cellular immunosuppression in rats.
Phytomedicine · 2026 Nov · PMID 42679469 · DOI 10.1016/j.phymed.2026.158725
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Inhalable solid lipid nanoparticles of cyclosporine A for prolonged pulmonary exposure: nano-in-micro particles prepared with fine droplet drying process.
Int J Pharm · 2026 Oct 5 · PMID 42571807 · DOI 10.1016/j.ijpharm.2026.127300
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Corrigendum to 'Cyclosporine A protects against wasp venom-induced rhabdomyolysis in rats by inhibiting the CypD-mPTP pathway' [Toxicon 281 (2026) 109187].
Toxicon · 2026 Oct 1 · PMID 42373385 · DOI 10.1016/j.toxicon.2026.109203
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Comparative evaluation of cyclosporine A and thymoquinone treatments in a benzalkonium chloride-induced experimental dry eye model.
Res Vet Sci · 2026 Oct · PMID 42322876 · DOI 10.1016/j.rvsc.2026.106306
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Cyclosporine A protects against wasp venom-induced rhabdomyolysis in rats by inhibiting the CypD-mPTP pathway.
Toxicon · 2026 Oct 1 · PMID 42276460 · DOI 10.1016/j.toxicon.2026.109187
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Colon-targeted mucin/cyclosporine A co-loaded microspheres synergistically ameliorate ulcerative colitis via immunosuppression and mucosal barrier repair.
Colloids Surf B Biointerfaces · 2026 Oct · PMID 42224972 · DOI 10.1016/j.colsurfb.2026.115858
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Effect of Conversion From Intravenous to Oral Administration on Cyclosporine Exposure in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
Ann Pharmacother · 2026 Oct · PMID 41630428 · DOI 10.1177/10600280251414685
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Pure Red Cell Aplasia Following Neoadjuvant Docetaxel/Carboplatin/Trastuzumab (TCbH) in a 45‑Year‑Old Woman With Breast Cancer Successfully Treated With Cyclosporine.
Am J Case Rep · 2026 Sep 25 · PMID 42789486 · DOI 10.12659/AJCR.952933
Source metadata only · evidence grade unassigned · scientific conclusions pending review
A picture of patients with chronic spontaneous urticaria undergoing cyclosporine treatment.
Eur Ann Allergy Clin Immunol · 2026 Sep 25 · PMID 42788891 · DOI 10.23822/EurAnnACI.1764-1489.455
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Combining pro-resolving therapy with cyclosporine A restores immune homeostasis and reduces toxicity in autoimmune bone marrow failure.
Cell Rep Med · 2026 Sep 24 · PMID 42785302 · DOI 10.1016/j.xcrm.2026.103074
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Nanomicelles self-assembled using cyclosporine A-hyaluronic acid conjugates for dry eye disease treatment.
Biomater Sci · 2026 Sep 21 · PMID 42764677 · DOI 10.1039/d6bm00870d
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Modulation of Nrf2/TNF-α and TLR4/TGF-β1 Signaling Pathways by Nigella Sativa Oil and Echinacea Purpurea Extract Attenuates Cyclosporine A-Induced Nephrotoxicity and Immunotoxicity.
Cell Biochem Biophys · 2026 Sep 18 · PMID 42758440 · DOI 10.1007/s12013-026-02167-0
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Efficacy and safety of different TPO-RAs combined with cyclosporine in the treatment of NSAA.
Ther Adv Hematol · 2026 · PMID 42756457 · DOI 10.1177/20406207261479584
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Deep learning-driven rare-event sampling reveals an Ala7/D-Ala8 conformational hinge governing amphiphilic switching in cyclosporine A.
Chem Commun (Camb) · 2026 Sep 15 · PMID 42621675 · DOI 10.1039/d6cc04209k
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Self-assembly of paclitaxel and cyclosporine A to overcome tumor drug resistance.
Colloids Surf B Biointerfaces · 2026 Sep 13 · PMID 42743868 · DOI 10.1016/j.colsurfb.2026.116183
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Comparative Efficacy of Cyclosporine, Tacrolimus, and Neurostimulatory Nasal Sprays for Moderate-to-Severe Dry Eye Disease: A Systematic Review and Network Meta-Analysis.
Clin Ophthalmol · 2026 · PMID 42788109 · DOI 10.2147/OPTH.S608369
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Anterior segment OCT-based assessment of efficacy of topical cyclosporine in edematous punctal stenosis.
Int Ophthalmol · 2026 Sep 10 · PMID 42720832 · DOI 10.1007/s10792-026-04253-x
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Long-term outcomes of eltrombopag plus cyclosporine A in eltrombopag-exposed patients with glucocorticoid-resistant or -dependent primary immune thrombocytopenia: a prospective, multicenter, single-arm, phase II study with extended follow-up.
Front Immunol · 2026 · PMID 42780154 · DOI 10.3389/fimmu.2026.1867103
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Safety and Efficacy of Nanomicellar 0.09% Cyclosporine for Treatment of Dry Eye Disease Refractory to 0.05% Cyclosporine Emulsion: A Single-Arm Prospective Switch Study.
Cornea · 2026 Sep 8 · PMID 42746723 · DOI 10.1097/ICO.0000000000004300
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Structural basis of Nur77-CypA interaction and cyclosporine A-mediated competitive displacement.
Biochem Biophys Res Commun · 2026 Sep 8 · PMID 42715887 · DOI 10.1016/j.bbrc.2026.154553
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Cyclosporine-A Nanotherapeutics Ameliorate Lupus Nephritis by Reprogramming the Gut-Microbial Metabolic Axis and Systemic Inflammation.
ACS Nano · 2026 Sep 8 · PMID 42708901 · DOI 10.1021/acsnano.6c03606
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Safety profiles of cyclosporine and tacrolimus in pregnancy: a pharmacovigilance analysis using the FDA Adverse Event Reporting System.
Front Med (Lausanne) · 2026 · PMID 42756046 · DOI 10.3389/fmed.2026.1917080
Source metadata only · evidence grade unassigned · scientific conclusions pending review
Obinutuzumab Compared to Cyclosporine with Steroids for the Treatment of Primary Membranous Nephropathy: A Propensity Score-Matched Analysis.
Kidney360 · 2026 Sep 2 · PMID 42684841 · DOI 10.34067/KID.0000001317
Source metadata only · evidence grade unassigned · scientific conclusions pending review

Loading research intelligence

Preparing the structured Flagship evidence library.